Hemodynamic benefits of regional anesthesia for carotid endarterectomy  by Sternbach, Yaron et al.
recent experience thus was undertaken to evaluate the
possible impact of each anesthetic technique on patient
hemodynamic profiles and the subsequent effect on hos-
pital course in the context of established critical pathways.
METHODS
A review was performed of the medical records of all
the patients who underwent nonemergent CEA by faculty
members of the Division of Vascular Surgery at the
University of Rochester between October 1998 and
November 2000. The patients who underwent treatment
with combined carotid and coronary artery revasculariza-
tion were excluded, as were those patients who needed
one or the other anesthetic technique for medical reasons.
Office and inpatient charts were reviewed.
All the patients underwent diagnostic carotid duplex
scanning before surgery in our vascular laboratory unless
they were referred after diagnostic angiography. Confir-
matory arteriography or magnetic resonance angiography
was performed in a minority of cases as indicated,
although routine angiography was not performed.
The choice of anesthetic technique was determined
according to surgeon preference, with an occasional
patient requesting one or the other technique. The choice
was dependent on the surgeon’s practice (or patient’s psy-
chology) and did not reflect bias according to medical sta-
tus. Induction of GA was performed according to the
preference of the anesthesiologist. Conventional inhala-
Hemodynamic instability during carotid endarterec-
tomy (CEA) is often a major concern in a patient popula-
tion beset by symptomatic or occult coronary artery
disease. Hypertension in particular has been implicated in
perioperative neurologic complications1,2 and may be
associated with increased use of critical care facilities and
longer hospital stays.3,4
The potential advantages of regional anesthesia for
CEA include more accurate neurologic monitoring with a
decreased need for intraoperative shunting and a reduc-
tion in risk associated with general anesthesia (GA) in a
high-risk population. Proponents also suggest that this
technique prevents excessive blood pressure instability
during and after surgery and a reduction in intraoperative
myocardial ischemia,5 which may be associated with fewer
complications and a more rapid discharge. Cervical block
anesthesia (CB) has been used interchangeably with GA
for elective carotid surgery in our division. A review of our
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Objective: The objective of this study was to define differences in perioperative hemodynamics and associated outcomes
in patients who undergo carotid endarterectomy (CEA) with regional and general anesthesia.
Methods: All the patients who underwent CEA during a 25-month period were reviewed, with a comparison of those
who underwent operation with cervical block anesthesia (CB) with those who underwent operation with general anes-
thetic (GA). Baseline intraoperative and postoperative blood pressure and heart rate were recorded, and deviation from
initial values was calculated. The administration of vasoactive medications was assessed. Operative time, intensive care
unit admission, postoperative length of stay, and cardiac/neurologic morbidity were recorded.
Results: From October 16, 1998, to December 1, 2000, 550 nonemergent CEAs were performed in 527 patients (226
with CB and 324 with GA). The patients in both groups were similar in age, presentation, and associated comorbidi-
ties. Although baseline blood pressure and heart rates were similar in both groups, those patients who underwent oper-
ation with GA had significantly greater intraoperative and postoperative hemodynamic variability and received more
vasoactive medications during surgery (87% versus 51%; P < .001) and in the recovery room (36% versus 21%; P =
.0009). Major postoperative blood pressure derangements were more common in the GA group (18% versus 10%; P <
.05). Patients who underwent operation with GA more frequently needed intensive care unit admission (16% versus
7%; P = .01) and had more frequent delays in discharge (20% versus 11%; P = .008; postoperative length of stay, 2.1
versus 1.6 days; P = .01). Although no difference was seen in neurologic morbidity rates between groups (combined
major stroke/death rate, 1.8%), the major cardiac morbidity rate was noted to be lower in the CB group (1% versus
4%; P = .05). The total in-room time was shorter in the CB group (108 versus 122 minutes; P < .001).
Conclusion: CEA performed with CB is associated with significantly less perioperative hemodynamic instability than
with GA. This results in fewer major adverse cardiac events. Ultimately, decreased critical care resource use is realized
as is a shortened length of stay. (J Vasc Surg 2002;35:333-9.)
tional anesthetic and oxygen mixture was used, occasion-
ally in conjunction with nitrous oxide. Regional anesthesia
was accomplished via a superficial CB only. This was per-
formed with the injection of approximately 10 to 15 mL of
a mixture of equal amounts of 0.5% bupivicaine hydrochlo-
ride (Astra Pharmaceuticals, Wilmington, Del) and 1%
lidocaine hydrochloride (Abbott Laboratories, North
Chicago, Ill) in the subcutaneous tissue at the incision site
and deep to the ipsilateral sternocleidomastoid and along
its posterior border. When necessary, 1% lidocaine was also
used in the field of dissection to supplement the anesthetic.
Occasionally, small doses of intravenous narcotic or mida-
zolam (Abbott Laboratories) were used as well, although
the patients were kept lucid and awake at all times.
Endarterectomy was performed with both eversion
and conventional techniques, with selection made accord-
ing to surgeon preference. Conventional endarterectomy
was used preferentially in patients with recent stroke in
whom shunting was planned or if test clamping produced
any electroencephalographic or neurologic changes.
The operating team and the anesthesiologist con-
versed with the patients who were awake, and direct visual
contact with the anesthesia team was maintained with the
lifting of the drapes over a Mayo stand. In all cases, con-
tinuous 32-lead electroencephalographic monitoring was
used with an attending neurologist present, but the deci-
sion to shunt was made on the basis of neurologic changes
only in the CB group. Shunting was performed for any
patient in the GA group who manifested any electroen-
cephalographic changes as interpreted in real time by the
neurologist.
Postoperative care proceeded according to a predeter-
mined critical pathway. The patients were observed in the
postanesthesia care unit (PACU) until hemodynamic sta-
bility could be ensured. All the preoperative medications
were restarted immediately. Antiplatelet medication was
administered to all the patients. Serial neurologic examina-
tions were performed. When vasoactive medications were
prescribed, attempts to treat with intermittent dosing were
made before the use of continuous infusions. No specific
hemodynamic values were targeted, although the patients
were generally allowed to settle near their baseline values.
Treatment depended on the deviation from each patient’s
baseline and on factors specific to each operation. Critical
care monitoring was used for patients with persistent
hemodynamic instability, neurologic changes, or marginal
cardiopulmonary status. Otherwise, transfer to the con-
ventional inpatient vascular unit was sought. Routine con-
tinuous cardiac monitoring via telemetry was maintained
on the initial postoperative night. Early ambulation was
encouraged, and drains, when present, were removed on
the first postoperative morning. Discharge on the 1st post-
operative day was routine. Occasionally, the patients were
observed an additional day, although anything longer was
considered a delay in discharge. Quantification of hemody-
namic variability was accomplished with the recording of
the heart rate (HR) and systolic blood pressure (SBP) dur-
ing the following time periods: the periods before, during,
and after clamping during operation; the PACU stay; and
each postoperative day as applicable. Variability was calcu-
lated as a fraction of the preoperative baseline value (mea-
sured by nurses at the time of admission to the hospital
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Table I. Indications for patient exclusion from analysis
No. of patients excluded
Concomitant coronary revasculariation 5
Excess medical risk (CB predetermined) 4
High risk airway (GA predetermined) 3
Anticipated high dissection (GA predetermined) 3
Emergent/urgent procedure (GA predetermined) 17
Total 32
CB, Cervical block anesthesia; GA, general anesthesia.
Table II. Profile of patients
Cervical block General anesthesia P value
Mean age (years) 72.3 71.0 NS
Male gender 60.2% 57.0% NS
CAD 58.2 54.7 NS
Hypertension 79.6 80.3 NS
Diabetes 30.6 27.4 NS
Renal failure 11.7 10.6 NS
Smoking 17.6 24.0 NS
Hyperlipidemia 47.7 56.0 NS
COPD 15.9 15.0 NS
CAD, Coronary artery disease; COPD, chronic obstructive pulmonary disease; NS, not significant.
before transfer to the preoperative area) and was expressed
as a percentage according to the following equation: (HR
or SBPmax – HR or SBPmin)/HR or SBPbaseline × 100.
The use of all supplemental vasoactive medications was
recorded for each time period. These medications
included parenterally administered alpha-receptor antago-
nists, nitrates, beta blockers, chronotropes, vagolytics, and
angiotensin-converting enzyme inhibitors. Omitted were
any of the patient’s regular medications taken before
surgery as directed by anesthesia.
The patients were categorized according to anesthetic
technique for purposes of comparison. Mortality and mor-
bidity were recorded. Neurologic complications included
transient or permanent deficits that arose immediately
after surgery or within the 30-day period after CEA.
Persistent deficits that resulted in significant disability or
functional impediment were considered major strokes,
and the remaining events were categorized as minor
events. Nonneurologic complications included cardiopul-
monary events, bleeding, hematoma, and infection.
Cardiac events included myocardial infarction (diagnosed
with clinical symptoms or electrocardiographic changes in
conjunction with elevation of cardiac enzymes), arrhyth-
mia that required intervention, angina, or congestive heart
failure. Pulmonary complications included bronchospasm
exacerbation, need for postoperative intubation, or reintu-
bation for distress and pneumonia. Other complications
noted included urinary retention and transient marginal
mandibular nerve dysfunction. Hypertensive and hypoten-
sive episodes were classified as significant if intensive care
unit (ICU) transfer or delay in discharge beyond day 2
occurred or if treatment was needed beyond baseline med-
ications. Length of stay and ICU admission requirements
were also assessed.
Statistical analysis was conducted with the Statview
5.0.1 (SAS Institute, Cary, NC). Comparison of discrete
JOURNAL OF VASCULAR SURGERY
Volume 35, Number 2 Sternbach et al 335
variables between groups was performed with χ2 test, and
continuous variables were assessed with unpaired t test.
Differences observed were considered to be statistically
significant at a P value of .05 or less.
RESULTS
During a 25-month period, 582 CEAs were per-
formed in 531 patients. Of these, 550 patients were
included in this analysis. The remaining 32 procedures
were excluded because of emergent indication, concomi-
tant coronary bypass grafting, or situations in which the
anesthetic technique was predetermined by factors other
than surgeon or patient preference (Table I).
Two hundred twenty-six patients underwent CEA with
CB, and 324 underwent CEA with GA. Preoperative
demographics and comorbidities (Table II) were similar in
both groups. Indications for operation (Table III) were
similar as well, with most patients undergoing surgery for
asymptomatic disease. A trend was observed toward
increased severity of ipsilateral occlusive disease in the CB
group (Table IV), although this was not mathematically
significant. No difference was observed in the severity of
contralateral disease or in the incidence rate of contralateral
occlusion. Eversion endarterectomy was more prevalent in
the GA group than in the CB group (GA, 53.3% versus
CB, 26.7%; P < .0001), which reflected surgeon bias.
Reoperative carotid surgery was also performed more often
with GA (GA, 4.4% versus CB, 0.4%; P < .006). The need
for intraoperative shunt placement was more common in
the GA group (GA, 18.8% versus CB, 12.6%; P = .004).
Although duration of carotid artery clamping (CB, 31.0
minutes versus GA, 30.8 minutes; P = not significant) and
actual operating times (CB, 79.2 minutes versus GA, 83.7
Table IV. Distribution of carotid disease
16% to 49% 50% to 79% 80% to 99%
CB 0.9% 25.1% 74.0%
GA 0.3% 35.4% 64.3%
CB, Cervical block; GA, general anesthesia.
Table V. Neurologic morbidity rates
Cervical block General anesthesia
(n = 226) (n = 324)
Death 2 1
TIA 1 1
Minor stroke 1 4
Major stroke 3 4
Total 6 (2.7%) 10 (3.1%)
TIA, Transient ischemic attack.
Table III. Indications for carotid endarterectomy
Cervical block General anesthesia P value
Asymptomatic 62.6% 54.8% NS
TIA 13.2% 15.2% NS
Crescendo TIA 2.2% 1.9% NS
Amaurosis/retinal symptoms 8.4% 9.3% NS
CVA < 6 weeks 4.4% 6.3% NS
CVA > 6 weeks 2.2% 2.5% NS
Nonhemispheric symptoms 7.1% 8.7% NS
TIA, Transient ischemic attack; CVA, cerebrovascular accident; NS, not significant.
minutes; P = not significant) did not differ between
groups, the total time spent in the operating room was
substantially shorter for patients in the CB group (CB,
107.8 minutes versus GA, 122.3 minutes; P < .0001).
There were three perioperative deaths in this series
(0.54%). No difference was noted between groups (CB,
0.89% versus GA, 0.31%; P = not significant). Two of the
deaths occurred in the CB group, and one was the result
of a significant hemorrhagic cerebrovascular event in an
asymptomatic patient. The other death was an elderly man
with bilateral carotid disease associated with crescendo
transient ischemic attacks. The patient had a symptomatic
severe unreconstructible ischemic cardiomyopathy and
succumbed to a fatal ventricular arrhythmia on the 2nd
postoperative day after an uneventful procedure. The third
death was a patient in the GA group and occurred after a
significant stroke.
Fourteen neurologic events occurred, for an overall
rate of 2.5%. These events were evenly split between major
strokes and minor strokes or transient deficits that
resolved in less than 24 hours (Table V). No difference
was noted in the neurologic event rate between groups
(CB, 2.2% versus GA, 2.8%). Similarly, the combined
stroke and death rate did not differ between the GA and
CB groups (CB, 2.2% versus GA, 2.8%). The incidence
rate of major stroke or death was 1.6%, with no difference
seen between anesthetic methods (CB, 1.8% versus GA,
1.5%; P = .84).
There were no significant differences in initial SBP or
HR obtained before arrival in the operating room.
Subsequent values obtained in the operating room before
induction showed no differences in SBP, but the patients
in the CB group had slightly higher HR just before inci-
sion (CB, 77.2 ± 13.2 versus GA, 72.5 ± 12.4; P = .007).
Once the surgery began, hemodynamic variability was
substantially greater in the GA group (Table VI).
Differences were most pronounced shortly after induction
of GA but persisted after clamping of the carotid artery
and through cerebral reperfusion. Associated with this
observation was a significantly greater use of vasoactive
medications during operation (GA, 87.3% versus CB,
50.5%; P < .0001).
In the PACU, those patients emerging from GA con-
tinued to show more pronounced fluctuations in blood
pressure and HR while continuing to need the adminis-
tration of additional vasoactive agents (GA, 36.3% versus
CB, 20.5%; P = .0009). This difference continued to be
observed through the 1st postoperative day, but no differ-
ences were observed beyond this point.
Significant postoperative hypertensive and hypotensive
episodes that required treatment were more common in
the GA group (GA, 17.8% versus CB, 10.3%; P < .03).
Hypertensive episodes represented the majority (71%) of
all postoperative blood pressure fluctuations that were
treated. With individual analysis of hypertensive and
hypotensive episodes, the GA group showed a trend
toward more frequent serious hypertension (12.7% versus
7.7%; P = .09), although no statistically significant differ-
ences were seen in hypotensive episodes. The overall inci-
dence rate of cardiac complications in this series was 4.0%,
with no significant difference seen between groups.
However, the occurrence of major adverse cardiac events
(myocardial infarction, congestive heart failure, ventricular
arrhythmia) was significantly reduced in the CB group (1%
versus 4%; P = .05; Table VII). Stable lone atrial fibrilla-
tion was classified as a minor cardiac event and did not
vary significantly between groups. Of the other complica-
tions after carotid surgery in our series, urinary retention
and transient marginal mandibular nerve dysfunction pre-
dominated. Also observed were significant nausea and
inadvertent falls. A greater proportion of such incidents
were observed in the patients who had undergone surgery
with GA (GA, 7.6% versus CB, 1%; P = .0009). The inci-
dence rate of headache and hematoma did not differ
between groups. Subgroup analysis results of the exami-
nation of all outcomes by gender, age, history of coronary
disease, or other factors failed to identify a population with
a statistically significant benefit.
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Table VI. Heart rate variability and systolic blood pressure variability
Cervical block General anesthesia P value
Heart rate variability
Preclamp 20% 34% <.0001
Clamped 17% 19% .02
Postclamp 14% 19% .001
PACU 21% 24% .02
POD 1 16% 21% .002
Systolic blood pressure variability
Preclamp 14% 28% .0001
Clamped 11% 14% .05
Postclamp 8% 15% .0001
PACU 17% 23% .0001
POD 1 14% 19% .0002
Heart rate variability: (Heart rate max – heart rate min × 100)/heart rate baseline.
Systolic blood pressure variability: (blood pressure max – blood pressure min × 100)/blood pressure baseline.
PACU, Postanesthesia care unit; POD, postoperative day.
Postoperative ICU care was deemed necessary in
11.9% of patients overall, with a marked preponderance in
the GA group (GA, 15.5% versus CB, 7.3%; P = .008).
Length of stay was also shorter in the CB group (CB, 1.6
days versus GA, 2.1 days; P = .026), with fewer patients
experiencing an unplanned delay in discharge (CB, 10.8%
versus GA, 20.2%; P < .008).
DISCUSSION
These data show a markedly increased incidence rate
of hemodynamic instability during CEA in patients who
undergo surgery with GA that persists into the early post-
operative period. Consequently, those patients who
undergo surgery with GA receive more vasoactive medica-
tions, more commonly need ICU admission, and have a
greater incidence rate of nonfatal postoperative complica-
tions as compared with those patients who undergo CEA
with superficial CB. Although rare, serious cardiac com-
plications are reduced in patients who undergo surgery
with CB, and neurologic events appear to be equally infre-
quent in both groups.
The prevalence of significant hemodynamic fluctua-
tion during carotid surgery is well recognized. In patients
who are frequently hypertensive at baseline and who often
harbor clinically apparent or occult coronary disease, the
impact of excess hemodynamic lability may be significant.
An association between hypertension and postoperative
neurologic compromise has previously been proposed.1,2
The condition may also contribute to bleeding episodes
that result in a hematoma or the need for reoperation.
Hypotension has also been implicated in the genesis of
untoward events after CEA.6 Although the importance of
appropriate HR control during CEA is less clear, avoiding
tachycardia does appear to benefit patients for vascular
surgery after operation.7
Mechanisms responsible for the fluctuations observed
remain elusive. Bradycardia is thought to occur at the time
of carotid bulb manipulation. The pathogenesis of post-
CEA hypertension is less clear. A number of neurohor-
monal pathways have also been proposed, with
vasopressin, norepinephrine, or renin advanced as possible
mediators of the response observed.8-10
Although choice of anesthetic technique varied
according to surgeon preference, the two groups were
nearly identical before operation. All the patients in whom
anesthetic technique was mandated by factors other than
surgeon or patient preference, in addition, were excluded.
The one major significant difference between groups was
the incidence rate of eversion versus conventional
endarterectomy. Previous reports suggest no major hemo-
dynamic derangement specifically associated with eversion
endarterectomy,11 and we believe this is not a likely source
of the dramatic differences observed, especially because
such changes began during the preclamp and clamp peri-
ods when the operative techniques had not yet diverged.
Operative times and major postoperative outcome vari-
ables, including neurologic morbidity and mortality rates,
were identical, which suggests that no major variations in
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operative technique or results existed according to sur-
geon. Although we cannot exclude all bias short of a
prospective, randomized trial, we believe the comparabil-
ity of the two groups otherwise support anesthetic tech-
nique as the source of these differences.
Although limited by the retrospective design of this
study (especially the inability to separate cause from effect
in the assessment of the purpose of intraoperative vasoac-
tive medication), these data remain particularly com-
pelling. In spite of similar comorbidities and baseline
hemodynamic parameters, the patients who underwent
carotid surgery with a regional anesthetic had significantly
smaller fluctuations of both SBP and HR than did the
patients with GA. These differences began with the induc-
tion of anesthesia and the start of surgery and persisted
throughout the operation, during the postoperative obser-
vation in the recovery room, and subsequently through
the 1st postoperative day. The largest difference, seen dur-
ing the preclamp period, likely reflects the effect of anes-
thetic induction. Whether this is strictly a pharmacologic
effect or the hormonal response to an additional stress
remains unclear. Associated with the increase in hemody-
namic variability is the increased use of vasoactive medica-
tions, both during surgery and afterward. Although
change in blood pressure or HR appeared to precipitate
the use of an initial vasoactive agent, the subsequent use of
additional medications, sometimes with the reverse effect,
may have enabled a pharmacologically induced pendulum
effect. Discerning the response to particular stimuli, such
as mechanical manipulation or volume changes from the
impact of anesthesia, continues to be problematic. Once
any significant hemodynamic deviation is observed, the
initiation of treatment with any vasoactive medication may
ultimately potentiate the innate response already under-
way and may pose additional risks for those patients with
existing coronary disease.12
The slight tachycardia exhibited by the CB group just
before anesthetic induction may be associated with preop-
erative anxiety, possibly as the result of the prospect of
remaining awake for a procedure perceived as risky.
Evidently, once surgery commences, any residual effect is
overshadowed by more pronounced intraoperative hemo-
dynamic shifts.
These data also have significant implications for effi-
ciency in resource use as suggested by Gabelman et al.13
The procedures performed with CB consumed less total
time in the operating room, and fewer such patients
needed observation in a critical care setting. This was
Table VII. Major cardiac morbidity rates
Cervical block General anesthesia
Myocardial infarction 1 5
Congestive heart failure 0 4
Ventricular arrhythmia 1 4
Total 2 (1%) 13 (4.0)
directly related to their hemodynamic stability with the
decreased need for additional blood pressure and HR con-
trol, findings similar to those reported by Eibes and
Gross14 as well as Bowyer and colleagues.15 Fewer
“minor” but clinically significant complications (such as
severe nausea, falls, and urinary retention) also occurred in
the CB group, an observation also made by Papavasiliou
et al.16 Although it is impossible to retrospectively identify
the ultimate effect in all cases, patients with CB had fewer
unplanned delays in discharge and went home sooner than
did those patients with GA.
Both cardiac complications and neurologic morbidity
rates were comparable in both groups. Subgroup analysis
results of the examination of outcomes by patient gender
and by history of coronary disease failed to identify a pop-
ulation with a statistically significant benefit. Neither did
the reoperative cases experience excess morbidity rates.
Given the observed frequency of such events, a substan-
tially greater number of study subjects may be required to
show a significant difference. Patients in the CB group had
fewer other complications, including urinary retention and
transient marginal mandibular nerve injury. This may, in
part, be related to infrequent bladder catheterization in
this group and a greater patient awareness of related
patient symptoms throughout the hospitalization.
It is noteworthy that the findings in this study were
obtained in a setting that is likely representative of many
other surgeons’ experience nationwide. There were neither
predetermined hemodynamic criteria that would trigger
the use of vasoactive medications nor particular guidelines
as to methods of induction or block placement. Goals for
blood pressure and HR were not set. Rather, these data
illustrate contemporary tertiary care surgical practice, anes-
thetic management, and perioperative care. Although indi-
vidual preferences should be acknowledged and may
certainly introduce bias, we attempted to exclude a variety
of cases, including emergent ones, in which a bias toward
an particular anesthetic technique could be introduced.
In summary, patients who undergo CEA with CB have
significantly less perioperative hemodynamic instability,
suffer fewer major cardiac complications, need ICU
admission less frequently, and experience shorter hospital
stays than do those patients with GA. This may result in
lower costs but certainly supports consideration of the
preferential use of CB in patients with substantial cardiac
risks who would tolerate large blood pressure and HR
shifts poorly.
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Dr Jonathan B. Towne (Milwaukee, Wis). This is a paper
about the type of anesthesia, since there was no difference in sur-
gical outcome between the two groups, both of which had excel-
lent morbidity and mortality. In my experience, the biggest
problem with blood pressure lability are severe hypertensives: in
particular, those who are poorly controlled. Because of this, we
will not do elective carotids in a patient who does not have well-
controlled hypertension.
My question to the authors, do they have any data that would
stratify their patients with hypertension in terms of severity of the
hypertension and then reanalyze their morbidity and mortality
according to this stratificaiton?
The overriding conclusion of this paper is that the blood
pressure lability induced by general anesthesia can cause an
increase in cardiac morbidity. If you stratify your data, in terms of
cardiac morbidity, including myocardial infarction, was there
more blood pressure lability in those patients who developed car-
diac complications?
The caution I would give, again using my own anecdotal
experience, is that I work with about six anesthesiologists and
general anesthesia is not the same among these six people. Their
techniques, how they handle the patients, how quickly they work
up, and the variety of medications they use vary widely. As you
look through your data, can you relate your complications to
anesthesia technique or even stratify them according to anesthesi-
ologist?
I enjoyed this paper and appreciate the opportunity to discuss it.
Dr Yaron Sternbach. We did not stratify by anesthesiologist,
though we certainly recognize that there are different anesthesi-
ologists who handled things differently. And perhaps the triggers
for certain anesthesiologists treating patients for certain blood
pressures are different and all this is not picked up in a retrospec-
tive analysis. So, we are aware of that.
We did try and do multiple subanalyses looking at which
patient group benefits more or less than others. And in our num-
bers, we did not come up with anything different from the group
as an aggregate. I am aware of some people, or some experiences,
that show that preoperative hypertension does predict postopera-
tive hypertension and hemodynamic instability. We did not strat-
ify our patients that way, although I guess in theory we can
certainly go back and try that.
Dr Thomas S. Riles (New York, NY). I certainly enjoyed the
paper, too, and as many of you know, our bias at NYU has always
been in favor of regional anesthesia. Nonetheless, we still perform
20% of our operations with general anesthesia. So, I think that it
is very important that a surgeon have both techniques in their
armamentarium.
You do demonstrate, however, that anesthetic agents can be
cardiotoxic. Fortunately, in most individuals, the effect is not sig-
nificant. But for the elderly patient with significant coronary
artery disease, this has to be taken into account.
I have one question. You included in your review 15 patients
that had reoperative carotid surgery. Fourteen of those were in
the general anesthesia group, and one had cervical block anesthe-
sia. I am curious to know if the reoperation had been excluded.
Do you think that the results would have been different?
Certainly reoperative procedure would add to the length of stay,
the time in the ICU, and the time in the recovery room.
Dr Sternbach. I do not think the outcome would be substan-
tially different knowing what we know about those patients. I
think that distribution reflects our institutional bias. I certainly
recognize that your group has previously published about suc-
cessful reoperative surgery with cervical block.
Dr Mark A. Adelman (New York, NY). I also work at NYU
and do a lot of carotid surgery with local anesthesia or regional
anesthesia as well. Oftentimes with the regional anesthetic, we
need to augment that anesthetic with local anesthesia in the
carotid sheath, anesthetizing the vagus nerve and the carotid
body. I wonder if any attention was given to local blockade in the
general anesthesia group? Was the amount of neural blockade
standardized in the general anesthesia group? Is it possible that
some of your results are attributable to those local anesthetic
blockades?
Dr Sternbach. Those are good points. We do not have the
data in such detail, so I cannot tell you about which carotid body
was blocked and which was not.
Dr Jack L. Cronenwett (Lebanon, NH). You acknowledged
that this was not a randomized trial, so could you tell us just how
these patients were selected, to convince us that there was not an
overt bias? More importantly, did you analyze the baseline char-
acteristics of these patients to demonstrate, for example, that the
general anesthetic group did not have a greater likelihood of
hypertensive or cardiac complications postoperatively?
Dr Sternbach. Well, I may never convince you completely
without a randomized series, but I think I tried to show you that
the comorbid factors were similar and the incidence rates of coro-
nary disease and hypertension were similar. So, the patients were
selected in such a way that any urgent surgery was excluded. The
way these patients typically were selected for either general anes-
thesia or cervical block was really based on surgeon preference
and to a great extent on patient psychology, so that they were
ready for it.
Dr Benjamin F. Gibbs, Jr (Rapid City, SD). My question has
to do with possible stratification of surgeons. Several years ago,
when I practiced in San Diego with Dr Vince Guzzetta, we
reviewed and reported upon surgeon-specific audits of carotid
endarterectomies performed in San Diego–area hospitals. It
seemed that postoperative hypertension occurred with longer
operations and that the efficient operations with brief occlusion
times had less hemodynamic instability.
My question is: are the surgeons who use local anesthesia
doing the operations in the same time frame as the surgeons who
use general anesthesia?
Dr Sternbach. Those are data that we actually do have, and
there is no time difference in either the carotid clamp time or in
the total operative time between groups. Where there is a differ-
ence is in the total time in the operating room from arrival to dis-
charge to the recovery room, where the cervical block patients
spend less time in the operating room. That may obviously have
some economic implications.
DISCUSSION
